Last updated on April 2019

Study of Rapastinel as Monotherapy in Patients With MDD


Brief description of study

The study will evaluate the efficacy, safety, and tolerability of 450 milligrams (mg) and 900 milligrams (mg) of Rapastinel, compared to placebo in participants with major depressive disorder (MDD).

Clinical Study Identifier: NCT03560518

Find a site near you

Start Over

Adams Clinical

Watertown, MA United States
0.39miles
  Connect »

Boston Clinical Trials

Boston, MA United States
6.7miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.